Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.400
+0.060 (2.56%)
Nov 21, 2024, 2:09 PM EST - Market open
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $301.35 million as of November 21, 2024. Its market cap has decreased by -1.56% in one year.
Market Cap
301.35M
Enterprise Value
184.78M
1-Year Change
-1.56%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $301.35M, an increase of 157.49%. That is a compound annual growth rate of 29.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 281.26M | -24.73% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 294.56M |
| Lyell Immunopharma | 291.79M |
| Silence Therapeutics | 290.15M |
| Immutep | 289.38M |
| OraSure Technologies | 286.81M |
| Vanda Pharmaceuticals | 285.42M |
| C4 Therapeutics | 284.47M |
| Accolade | 280.67M |